(1)
Weng, J.; Huang, A.; Berake, T. B.; Chen, S. L.; Yan, B. M.; Karagozian, R. Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterol Res 2026, 19 (3), 147-154. https://doi.org/10.14740/gr2136.